Completed PHASE3 INTERVENTIONAL 1-arm NCT00902746

Efficacy and Safety, Long-Term Study of NPC-01 to Treat Dysmenorrhea Associated With Endometriosis

Phase3, Open-Label, Long-Term, NSAID-Add-on, Clinical Trial of NPC-01 for Treatment of Dysmenorrhea Associated With Endometriosis.

Sponsor: Nobelpharma

Conditions Dysmenorrhea

Interventions NPC-01

Updated 6 times since 2017 Last updated: Jun 3, 2025 Started: May 31, 2009 Primary completion: Feb 29, 2012 Completion: Feb 29, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Dysmenorrhea, this trial is completed. The trial is conducted by Nobelpharma and has accumulated 6 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Jul 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Jul 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

May 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nobelpharma

Data source: Nobelpharma

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.